Sign In
Buy CI
$274.05
-8.01 (-2.84%)
At Close: Aug 04, 2026
10 High-Yield A-Rated Blue-Chips For Potentially Scary Times Ahead
07:00am, Friday, 30'th Aug 2024
The economy is stable but cooling, with the labor market showing signs of slowing down. GDP growth is likely to keep falling, and individual companies could suffer. Long-term investors should focus on
JERSEY CITY, N.J. , Aug. 28, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scrip
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
12:36pm, Monday, 26'th Aug 2024
Cigna said on Monday it will remove AbbVie's blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar vers
Here's Why Cigna (CI) is a Strong Momentum Stock
10:50am, Thursday, 22'nd Aug 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Cigna Group Announces Appearance at the Morgan Stanley 22nd Annual Global Healthcare Conference
09:00am, Thursday, 15'th Aug 2024
BLOOMFIELD, Conn., Aug. 15, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that David Cordani, Chairman and Chief Executive Officer, will present at the Morgan
The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health
07:00am, Monday, 12'th Aug 2024
Initiative commits $9M over three years, with a first-year focus on housing stability Request for application now open for nonprofits prioritizing veteran mental health with programs and services dire
Stocks To Hold To Year End
02:24pm, Sunday, 11'th Aug 2024
Seasonal trading can be a benefit in stock selection. For an unknown reason, some equities perform well in some parts of the year and poorly in other parts of the year.
The 3 Best Bargain Stocks to Buy in August 2024
05:31pm, Wednesday, 07'th Aug 2024
Since July 16, volatility in the markets has increased. Stocks have entered correction territory, with the Nasdaq 100 down 13% from its peak.
The Cigna Group Foundation Announces Grants to 22 Nonprofits to Help Address the Youth Mental Health Crisis
07:00am, Monday, 05'th Aug 2024
BLOOMFIELD, Conn. , Aug. 5, 2024 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced its first round of grant recipients for its new initi
5 Relatively Secure And Cheap Dividend Stocks To Invest In -- August 2024
09:00am, Saturday, 03'rd Aug 2024
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
Cigna (CI) Q2 Earnings Top on Specialty Business Strength
03:11pm, Thursday, 01'st Aug 2024
Cigna's (CI) Q2 results reflect new client wins in the Evernorth Health Services unit, partly offset by elevated pharmacy costs. It continues to expect adjusted EPS of at least $28.40 for 2024.
The Cigna Group (CI) Q2 2024 Earnings Call Transcript
12:00pm, Thursday, 01'st Aug 2024
The Cigna Group (NYSE:CI ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Ralph Giacobbe - SVP of IR David Cordani - Chairman and CEO Brian Evanko - CFO, and President
Cigna (CI) Reports Q2 Earnings: What Key Metrics Have to Say
10:36am, Thursday, 01'st Aug 2024
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
08:10am, Thursday, 01'st Aug 2024
Cigna (CI) came out with quarterly earnings of $6.72 per share, beating the Zacks Consensus Estimate of $6.42 per share. This compares to earnings of $6.13 per share a year ago.
Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost
06:04am, Thursday, 01'st Aug 2024
Cigna reported a second-quarter profit on Thursday that beat Wall Street estimates, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit.
